Dark

ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
stock NASDAQ

At Close

Jul 17, 2026 3:59:59 PM EDT

6.06USD-2.100%(-0.13)429,584

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 17, 2026 9:13:30 AM EDT

6.08USD-1.777%(-0.11)411

After-hours

Jul 17, 2026 4:21:30 PM EDT

6.03USD-0.495%(-0.03)63,687

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

10:29AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 Benzinga

07:59AM EST Raymond James Upgrades Arcturus Therapeutics to Market Perform Benzinga

Jan 25, 2022

08:09AM EST Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response To The SARS-CoV-2 Omicron Variant From ARCT-154 And ARCT-165 Booster Clinical Trial Benzinga

Jan 24, 2022

08:03AM EST Arcturus Therapeutics Updates Data From ARCT-154 And ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses To SARS-CoV-2 And Several Variants Benzinga

Jan 18, 2022

07:00AM EST Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief GlobeNewswire Inc

Dec 16, 2021

08:38AM EST Arcturus Therapeutics Reports New Data, Provides Additional Updates From ARCT-154 And ARCT-165 Clinical Trials; Co To Evaluate Sera From Vaccinated Participants For Activity Against Omicron Variant Benzinga

Nov 9, 2021

11:33AM EST Barclays Maintains Underweight on Arcturus Therapeutics, Lowers Price Target to $31 Benzinga

11:02AM EST Arcturus Therapeutics Q3 EPS $(2.05) Misses $(1.59) Estimate, Sales $2.40M Up From $2.33M YoY Benzinga

Nov 8, 2021

05:06AM EST Earnings Scheduled For November 8, 2021 Benzinga

Oct 12, 2021

08:11AM EDT Arcturus Therapeutics Announces Approval From Vietnam Ministry Of Health To Proceed Into Phase 3b Study For ARCT-154, A Next Generation STARR mRNA Vaccine Targeting SARS-CoV-2 Delta Variant And Other Variants Of Concern Benzinga

Sep 27, 2021

08:10AM EDT CORRECTION: Arcutis Biotherapeutics Ticker Is 'ARQT' Benzinga

08:09AM EDT Arcutis Biotherapeutics to Present Data At European Academy of Dermatology and Venereology (EADV) Congress. Benzinga

Sep 23, 2021

09:12AM EDT Arcturus Therapeutics Files For U.S. Patent Titled 'CORONAVIRUS VACCINE COMPOSITIONS AND METHODS' Benzinga

Sep 22, 2021

04:02PM EDT Arcturus Therapeutics Announces Meeting With President Of Vietnam, CEO Of Vingroup To Discuss Expansion Of COVID-19 Vaccine Collaboration Benzinga

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

07:03AM EDT Arcturus Therapeutics Announces Approval From Vietnam Ministry Of Health To Proceed Into Phase 2 And Phase 3a For ARCT-154, Next Generation STARR mRNA Vaccine Targeting SARS-CoV-2 Delta Variant And Other Variants Of Concern Benzinga

Sep 15, 2021

12:04PM EDT Arcturus Therapeutics Earnings Perspective: Return On Capital Employed Benzinga

Aug 31, 2021

12:35PM EDT Expert Ratings For Arcturus Therapeutics Benzinga

Aug 25, 2021

12:52PM EDT Analyst Ratings For Arcturus Therapeutics Benzinga

09:55AM EDT Citigroup Maintains Buy on Arcturus Therapeutics, Lowers Price Target to $114 Benzinga

Aug 12, 2021

12:14PM EDT Mid-Day Market Update: ExOne Rises Following Acquisition News; LifeStance Health Shares Plummet Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021 Benzinga

06:24AM EDT Raymond James Downgrades Arcturus Therapeutics to Underperform Benzinga

Aug 11, 2021

10:08AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2021 Benzinga

04:53AM EDT Goldman Sachs Downgrades Arcturus Therapeutics to Sell, Announces $29 Price Target Benzinga

Aug 10, 2021

10:44AM EDT Cantor Fitzgerald Maintains Overweight on Arcturus Therapeutics, Raises Price Target to $85 Benzinga

10:32AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2021 Benzinga

10:15AM EDT Arcturus Therapeutics Holdings Inc. (ARCT) shares are rising more than 27 percent on Tuesday morning trade after the company announced the selection of its ARCT-021 by a global entity to include in phase 3 vaccine trial and an agreement with Vinbiocare in Vietnam to manufacture its investigational COVID-19 vaccines. The company reported a wider net loss for the second quarter. RTTNews

08:26AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Aug. 10, 2021: AMC, ZEV, FUBO, FSR, ARCT Benzinga

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

07:40AM EDT Baird Downgrades Arcturus Therapeutics to Underperform Benzinga

Aug 9, 2021

06:03PM EDT UPDATE: Arcturus Therapeutics Q2 EPS $(2.07) Beats $(2.14) Estimate, Sales $2.00M Miss $2.32M Estimate Benzinga

04:22PM EDT Arcturus Therapeutics Reports 'ARCT-021, Arcturus' single shot STARR mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study funded and sponsored by a global entity' Benzinga

04:20PM EDT Arcturus Therapeutics Q2 EPS $(2.07) Beats $(2.14) Estimate Benzinga

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Aug 3, 2021

02:31PM EDT Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge Benzinga

02:01PM EDT Arcturus Therapeutics Shares See Volume; B Riley Sets $23 Price Target Benzinga

12:12PM EDT Mid-Day Market Update: Crude Oil Down 2%; Arcturus Therapeutics Shares Spike Higher Benzinga

10:19AM EDT Arcturus Therapeutics Holdings Inc. (ARCT) shares are trading more than 28 percent higher on Tuesday morning after the company reported approval of Singapore clinical trial application to advance ARCT-154 and ARCT-165. RTTNews

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

07:04AM EDT Arcturus Announces Approval Of Singapore Clinical Trial Application To Advance ARCT-154 And ARCT-165, Next Generation STARR mRNA Vaccines Targeting SARS-CoV-2 Variants Of Concern, In A Phase 1/2 Study Benzinga

Aug 2, 2021

11:22AM EDT Arcturus' COVID-19 mRNA Vaccine Candidate To Target Variants, Trial To Start In Vietnam Benzinga

09:08AM EDT Arcturus Therapeutics Stock Jumps On Establishment Of COVID-19 Vaccine Plant In Vietnam Benzinga

09:03AM EDT Arcturus Partner, Vinbiocare, Receives Clinical Trial Application From Vietnam Ministry Of Health To Advance ARCT-154 Benzinga

07:02AM EDT Arcturus Therapeutics Collaborates With Vingroup To Establish Manufacturing Facility In Vietnam For Arcturus' Investigational mRNA Vaccines For COVID-19; Co. To Receive $40M Upfront Payment And Potential Royalties Based On Vaccines Produced Benzinga

Jul 28, 2021

08:32AM EDT Arcuturs Reports Regulatory Approval To Proceed With Phase 2 Study Of ARCT-810 mRNA Therapeutic Candidate For Ornithine Transcarbamylase Deficiency Benzinga

Jul 2, 2021

10:08AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021 Benzinga

07:17AM EDT Cantor Fitzgerald Initiates Coverage On Arcturus Therapeutics with Overweight Rating, Announces Price Target of $71 Benzinga

Jun 24, 2021

09:50AM EDT Return On Capital Employed Overview: Arcturus Therapeutics Benzinga

Jun 21, 2021

10:15AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021 Benzinga

07:53AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:16AM EDT Barclays Downgrades Arcturus Therapeutics to Underweight, Lowers Price Target to $25 Benzinga

Jun 8, 2021

11:36AM EDT Looking Into Arcturus Therapeutics's Return On Capital Employed Benzinga

Jun 2, 2021

09:04AM EDT Arcturus Therapeutics Granted Exclusive License Of RNA Polymerase For Human And Animal Therapeutics By Primordial Genetics Benzinga

09:03AM EDT Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA PR Newswire

May 14, 2021

07:59AM EDT The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 10, 2021

04:51PM EDT Arcturus Therapeutics: Q1 Earnings Insights Benzinga

04:22PM EDT Arcturus Therapeutics Q1 EPS $(2.15) Misses $(1.25) Estimate, Sales $2.13M Miss $2.54M Estimate Benzinga

04:09AM EDT Earnings Scheduled For May 10, 2021 Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 3, 2021

04:40PM EDT Arcutis Biotherapeutics To Present New Roflumilast Cream Phase 3 Data At The European Academy of Dermatology and Venereology Spring Symposium May 6-7, 2021 Benzinga

Mar 1, 2021

05:26PM EST Arcturus Therapeutics: Q4 Earnings Insights Benzinga

04:04PM EST Arcturus Therapeutics Q4 EPS $(1.25) Misses $(0.88) Estimate, Sales $2.24M Miss $2.36M Estimate Benzinga

03:51AM EST Earnings Scheduled For March 1, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 22, 2021

08:07AM EST Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals Benzinga

Jan 15, 2021

10:31AM EST B. Riley FBR Downgrades Arcturus Therapeutics to Neutral, Lowers Price Target to $77 Benzinga

10:05AM EST Hearing B. Riley Downgraded Arcturus Therapeutics Stock To Neutral Benzinga

Jan 8, 2021

02:09PM EST Federated Hermes Reports In 13G Filing A 13.35% Stake In Arcturus Therapeutics Holdings Benzinga

Jan 7, 2021

12:10PM EST Benzinga's Top Upgrades, Downgrades For January 7, 2021 Benzinga

06:20AM EST Wells Fargo Initiates Coverage On Arcturus Therapeutics with Overweight Rating Benzinga

Jan 4, 2021

07:07AM EST Arcturus Therapeutics Receives FDA Allowance To Proceed With Phase 2 Study Of ARCT-021 (LUNAR-COV19) Vaccine Candidate In United States Benzinga

Dec 30, 2020

07:46AM EST Arcturus Therapeutics Announces That It Has Selected ARCT-032 As A Development Candidate For Cystic Fibrosis And Progressive Hereditary Disease Benzinga

Dec 29, 2020

02:31PM EST Mid-Afternoon Market Update: Dow Falls Over 100 Points; Silver Down 1% Benzinga

02:26PM EST Mid-Morning Market Update: Markets Mixed; House Passes $2,000 Direct Payments Benzinga

02:26PM EST Mid-Day Market Update: Crude Oil Rises 1%; Arcturus Therapeutics Shares Drop Benzinga

10:23AM EST Mid-Morning Market Update: Markets Mixed; House Passes $2,000 Direct Payments Benzinga

10:12AM EST Benzinga's Top Upgrades, Downgrades For December 29, 2020 Benzinga

10:04AM EST Shares of Arcturus Therapeutics Holdings Inc. (ARCT) more than halved on Tuesday morning despite the clinical stage company announcing that it received approval to start phase 2 study for its Covid vaccine candidate. RTTNews

09:49AM EST Return On Capital Employed Overview: Arcturus Therapeutics Benzinga

09:11AM EST 7 Biggest Price Target Changes For Tuesday Benzinga

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

07:09AM EST Raymond James Downgrades Arcturus Therapeutics to Market Perform Benzinga

06:43AM EST HC Wainwright & Co. Downgrades Arcturus Therapeutics to Neutral, Lowers Price Target to $50 Benzinga

06:26AM EST Baird Downgrades Arcturus Therapeutics to Neutral, Lowers Price Target to $69 Benzinga

Dec 28, 2020

04:02PM EST Arcturus Therapeutics Announces Approval From Singapore Health Sciences Authority To Proceed With Phase 2 Study Of ARCT-021 (LUNAR-COV19) Vaccine Candidate And Provides New And Updated Clinical And Preclinical Data Benzinga

Dec 23, 2020

10:07AM EST Benzinga's Top Upgrades, Downgrades For December 23, 2020 Benzinga

09:02AM EST Roth Capital Downgrades Arcturus Therapeutics to Sell, Announces $77 Price Target Benzinga

Dec 16, 2020

10:00AM EST 10 Healthcare Stocks That Thrived In 2020 Benzinga

Dec 8, 2020

02:31PM EST Mid-Afternoon Market Update: Dow Jumps 150 Points; Stitch Fix Shares Gain On Upbeat Q1 Earnings Benzinga

12:28PM EST Mid-Day Market Update: US Stocks Turn Positive; Arcturus Therapeutics Shares Plunge Benzinga

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 7, 2020

04:34PM EST Arcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not Disclosed Benzinga

04:33PM EST Arcturus Therapeutics Announces Proposed Public Offering of Common Stock Business Wire

07:05AM EST Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency Benzinga

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Nov 27, 2020

12:20PM EST Mid-Day Market Update: Nasdaq Surges 100 Points; Sorrento Therapeutics Shares Spike Higher Benzinga

Nov 10, 2020

08:18AM EST Raymond James Maintains Outperform on Arcturus Therapeutics, Lowers Price Target to $73 Benzinga

Nov 9, 2020

04:10PM EST Arcturus Therapeutics Q3 EPS $(0.92) Misses $(0.49) Estimate, Sales $2.33M Miss $3.00M Estimate Benzinga

02:30PM EST Mid-Afternoon Market Update: Dow Surges Over 1300 Points; Arcturus Therapeutics Shares Slide Benzinga

12:40PM EST Mid-Day Market Update: Crude Oil Jumps Over 9%; HighPoint Resources Shares Plummet Benzinga

07:13AM EST Arcturus Therapeutics Announces Positive Interim ARCT-021 (LUNAR-COV19) Phase 1/2 Study Results for Both Single Shot and Prime-boost Regimens, and Up to $220M in Additional Financial Commitments from Singapore Benzinga

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 30, 2020

03:13PM EDT Arcturus Therapeutics Option Alert: Dec 18 $80 Calls Sweep (12) near the Bid: 134 @ $2.6 Benzinga

Oct 26, 2020

10:22AM EDT Arcturus Therapeutics Holdings Inc. (ARCT) shares are gaining on Monday morning, in spite of no announcement by the company to influence the stock. RTTNews

Oct 6, 2020

10:14AM EDT Benzinga's Top Upgrades, Downgrades For October 6, 2020 Benzinga

07:28AM EDT Citigroup Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $65 Benzinga

Oct 5, 2020

02:27PM EDT Why Arcturus Therapeutics Is Trading Higher Today Benzinga

08:08AM EDT Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase Deficiency Benzinga

Sep 8, 2020

08:30AM EDT Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at upcoming investor and scientific conferences virtually: GlobeNewswire Inc

Sep 4, 2020

11:00AM EDT Arcturus Therapeutics Holdings Inc. (ARCT), Friday announced that its manuscript is now available on an online preprint server at Bioarchive and is concurrently undergoing scientific peer review. RTTNews

10:37AM EDT Arcturus Therapeutics Reports Preclinical Publication Of COVID-19 Vaccine Candidate RTTNews

10:34AM EDT Arcturus Therapeutics Announces Preclinical Publication Of Coronavirus Vaccine Candidate; Says 'Encouraging Preclnical Results" Demonstrate Strong Antibody, Cellular Immune Response And '100% Protection' Against Infection Following Single Vaccination Benzinga

10:32AM EDT Encouraging preclinical results demonstrate a strong antibody and cellular immune response and 100% protection against SARS-CoV-2 infection following a single vaccination GlobeNewswire Inc

Aug 26, 2020

06:25AM EDT Piper Sandler Initiates Coverage On Arcturus Therapeutics with Overweight Rating, Announces Price Target of $77 Benzinga

Aug 24, 2020

05:47PM EDT VivoPower International PLC (VVPR) - Shares of the nano-cap solar power company jumped 55% in after hours trade on top of a 25% growth in regular trade on Monday. The company had reported results for the full-year 2020, with revenues increasing 12% and net loss narrowing from a year ago. RTTNews

Aug 18, 2020

09:08AM EDT Arcturus Therapeutics Executes Definitive Supply Agreement With The Israeli Ministry Of Health Benzinga

09:00AM EDT Arcturus Therapeutics Executes Definitive Supply Agreement with GlobeNewswire Inc

Aug 11, 2020

08:10AM EDT Arcturus Therapeutics Initiates Dosing Of COVID-19 STARR MRNA Vaccine Candidate, LUNAR-COV19 In A Phase 1/2 Study RTTNews

08:02AM EDT Arcturus Therapeutics Announces It Has Initiated Dosing Of Its Coronavirus STARR mRNA Vaccine Candidate, LUNAR-COV19 In Phase 1/2 Study Benzinga

07:58AM EDT Raymond James Maintains Outperform on Arcturus Therapeutics, Raises Price Target to $79 Benzinga

Aug 10, 2020

04:24PM EDT Arcturus Therapeutics Q2 EPS $(0.55), Inline, Sales $2.32M Miss $3.54M Estimate Benzinga

04:01PM EDT COVID-19 STARR mRNA vaccine candidate, ARCT-021 (LUNAR-COV19) has initiated Phase 1/2 clinical study with Duke-NUS Medical School; Dosing anticipated imminently, initial data expected Q4 GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Aug 6, 2020

11:37AM EDT Arcturus Therapeutics Appoints Lance Kurata as Chief Legal Officer Benzinga

Aug 4, 2020

08:30AM EDT Arcturus Therapeutics to Report Second Quarter 2020 Financial GlobeNewswire Inc

Jul 30, 2020

12:49PM EDT Roth Capital Reinstates Buy on Arcturus Therapeutics, Announces $77 Price Target Benzinga

Jul 28, 2020

04:09PM EDT Arcturus Therapeutics Announces A Common Stock Offering; No Size Disclosed Benzinga

04:01PM EDT Arcturus Therapeutics Announces Proposed Public Offering of Common GlobeNewswire Inc

Jul 24, 2020

08:21AM EDT HC Wainwright & Co. Maintains Buy on Arcturus Therapeutics, Raises Price Target to $78 Benzinga

Jul 23, 2020

04:03PM EDT Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV19 Benzinga

04:02PM EDT Arctururs Therapeutics Announces Agreement With Israeli Ministry Of Health To Supply Coronavirus Vaccine Candidate, LUNAR-COV19 BZ NOTE: The Times Of Israel Reported This Earlier Benzinga

04:01PM EDT Israel secures rights to stockpile and reserve doses of LUNAR-COV19 for its citizens GlobeNewswire Inc

01:52PM EDT 'Israel said expected to ink deal with US firm developing COVID-19 vaccine' -Times Of Israel Report Benzinga

Jul 21, 2020

08:39AM EDT Arctururs Therapeutics & Duke-NUS Received Approval To Proceed With Phase 1/2 Clinical Trial For Coronavirus Vaccine Candidate, LUNAR-COV19 Benzinga

08:30AM EDT Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with GlobeNewswire Inc

Jul 16, 2020

07:23AM EDT Raymond James Initiates Coverage On Arcturus Therapeutics with Outperform Rating, Announces Price Target of $72 Benzinga

Jul 13, 2020

10:54AM EDT B. Riley FBR Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $70 Benzinga